These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14653828)

  • 41. Non-erosive reflux disease compared with erosive esophagitis with regards to acid reflux and symptom patterns.
    Frootan M; Choobtashani S; Azargashb E; Amin PM; Hamide M; Zali MR; Haleh A
    Turk J Gastroenterol; 2011 Oct; 22(5):464-71. PubMed ID: 22234752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis.
    Nakamura T; Shirakawa K; Masuyama H; Sugaya H; Hiraishi H; Terano A
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():19-26. PubMed ID: 15943842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oesophageal acid clearance in patients with severe reflux oesophagitis.
    Barham CP; Gotley DC; Mills A; Alderson D
    Br J Surg; 1995 Mar; 82(3):333-7. PubMed ID: 7796001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Appropriate acid suppression for the management of gastro-oesophageal reflux disease.
    Bell NJ; Burget D; Howden CW; Wilkinson J; Hunt RH
    Digestion; 1992; 51 Suppl 1():59-67. PubMed ID: 1397746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?
    Tack J; Fass R
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():28-34. PubMed ID: 14725576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease.
    Katz PO
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():3-11. PubMed ID: 16483265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review article: gastric pH -- the most relevant predictor of benefit in reflux disease?
    Armstrong D
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():19-26; discussion 38-9. PubMed ID: 15456460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment.
    Pace F; Sangaletti O; Bianchi Porro G
    Gut; 1990 Sep; 31(9):1025-9. PubMed ID: 2210448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alkaline gastro-oesophageal reflux: dual probe pH monitoring.
    Iftikhar SY; Ledingham S; Evans DF; Yusuf SW; Steele RJ; Atkinson M; Hardcastle JD
    Gut; 1995 Oct; 37(4):465-70. PubMed ID: 7489929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there a relationship between Helicobacter pylori infection and erosive reflux disease in children?
    Emiroglu HH; Sokucu S; Suoglu OD; Gulluoglu M; Gokce S
    Acta Paediatr; 2010 Jan; 99(1):121-5. PubMed ID: 19785631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole.
    Klinkenberg-Knol EC; Meuwissen SG
    Aliment Pharmacol Ther; 1990 Oct; 4(5):485-95. PubMed ID: 2129636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does body posture affect the incidence and mechanism of gastro-oesophageal reflux?
    Freidin N; Mittal RK; McCallum RW
    Gut; 1991 Feb; 32(2):133-6. PubMed ID: 1864529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Composition of gastro-oesophageal refluxate.
    Gotley DC; Morgan AP; Ball D; Owen RW; Cooper MJ
    Gut; 1991 Oct; 32(10):1093-9. PubMed ID: 1955160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage.
    Bredenoord AJ; Hemmink GJ; Smout AJ
    Neurogastroenterol Motil; 2009 Aug; 21(8):807-12. PubMed ID: 19374635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
    Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R
    Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multivariate analysis of pathophysiological factors in reflux oesophagitis.
    Cadiot G; Bruhat A; Rigaud D; Coste T; Vuagnat A; Benyedder Y; Vallot T; Le Guludec D; Mignon M
    Gut; 1997 Feb; 40(2):167-74. PubMed ID: 9071926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
    Bretagne JF; Rey JF; Caekaert A; Barthélemy P
    Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determinants of oesophageal 'alkaline' pH environment in controls and patients with gastro-oesophageal reflux disease.
    Singh S; Bradley LA; Richter JE
    Gut; 1993 Mar; 34(3):309-16. PubMed ID: 8472976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.